|
 
 |
| OPHTHALMIC IMAGE |
|
| Year : 2023 | Volume
: 3
| Issue : 2 | Page : 616 |
|
“Impitoyable petale:” The unforgiving flower
Shubham Manchanda, Savleen Kaur, Jaspreet Sukhija
Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| Date of Web Publication | 28-Apr-2023 |
Correspondence Address:
Savleen Kaur
Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/IJO.IJO_3350_22
How to cite this article:
Manchanda S, Kaur S, Sukhija J. “Impitoyable petale:” The unforgiving flower. Indian J Ophthalmol Case Rep 2023;3:616 |
An 8-year-old boy presented with decreased vision. He was a known case of nephrotic syndrome on oral steroids for the past 2 years before presentation.
On examination, his best-corrected visual acuity was 20/40 in both eyes, with intraocular pressure of 16 mm. The child was photographed on the slit lamp after pupillary dilation, which revealed a petaloid steroid-induced cataract in both eyes [Figure 1]. | Figure 1: Eight-year-old boy, a known case of nephrotic syndrome, presented with decreased vision. The child was photographed on the slit lamp after pupillary dilation, which revealed a petaloid steroid-induced cataract in both eyes (a). The retroillumination picture is also attached (b). This case highlights the importance of regular ophthalmic examination in children diagnosed with nephrotic syndrome and prescribed steroids
Click here to view |
This clinical case highlights that physicians treating nephrotic syndrome should be warned of steroid-related complications like cataracts and glaucoma in the eye, hence the need for meticulous ophthalmological examination at regular intervals in such patients.[1],[2]
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient (s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initial s will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Nakubulwa F, Lusobya RC, Batte A, Ssuna B, Nakanjako D, Nakiyingi L, et al. Prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment in a resource-limited setting. BMC Ophthalmol 2021;21:55.  |
| 2. | Christian MT, Maxted AP. Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2022;37:37-47. |
[Figure 1]
|
Search Pubmed for